How short high-oxygen exposures affect brain blood flow during mechanical ventilation
Official title: HYPERMIND - Hyperoxia Effects on Cerebral Hemodynamics
Run by Erasme University Hospital · NCT07377162 · Data updated 2026-11-12
We will test whether brief, controlled increases in ventilator oxygen change brain blood flow in adults who are intubated and on mechanical ventilation in the ICU.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Erasme University Hospital Academic / other |
| Locations | 1 site (Brussels) |
| Status | Recruiting |
| Started | January 1, 2024 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2028 |
| Registry record updated | January 29, 2026 |
| Trial ID | NCT07377162 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) in the ICU who are intubated and on volume-controlled mechanical ventilation for ≤72 hours, have PaCO2 35–45 mmHg, invasive arterial monitoring, and an adequate TCD acoustic window are ideal candidates.
✕Probably not a fit
Patients on ECMO or continuous renal replacement therapy, pregnant patients, those without a usable TCD window, or those with severe hemodynamic instability likely will not benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Mechanically ventilated adult ICU patients will undergo stepwise increases in the fraction of inspired oxygen (FiO2) while continuous transcranial Doppler (TCD) monitoring of the middle cerebral artery records cerebral blood flow velocity. Patients with baseline FiO2 < 0.5 will receive two hyperoxic steps (FiO2 0.5 then 1.0) and those with baseline FiO2 ≥ 0.5 will receive a single step (FiO2 1.0), each with a ~5-minute stabilization and a 10-minute recording period. Arterial blood gases will be sampled at baseline, at the end of each hyperoxic step, and after return to baseline, while ventilation, sedation, and vasoactive drug rates are kept constant. The protocol uses non-invasive monitoring and no additional invasive procedures beyond standard ICU care.
Why it matters
Potential benefit: If successful, this could help clinicians set oxygen levels that avoid harmful changes in brain blood flow for ventilated ICU patients.
How similar studies have gone: Prior physiological studies in volunteers and some patient groups have shown that hyperoxia can reduce cerebral blood flow, but continuous TCD data in mechanically ventilated ICU patients are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria * Adult patients aged ≥18 years * Admitted to the intensive care unit (ICU) * Intubated and mechanically ventilated for ≤72 hours * Receiving volume-controlled mechanical ventilation * Arterial partial pressure of carbon dioxide (PaCO₂) between 35 and 45 mmHg * Invasive arterial blood pressure monitoring in place * Adequate transcranial Doppler (TCD) acoustic window * Clinically judged to be suitable for a brief normobaric hyperoxic stimulus * Expected to receive one or two hyperoxic steps based on baseline FiO₂ requirements: a) Baseline FiO₂ \< 0.5: two-step hyperoxic stimulus (FiO₂ 0.5 followed by FiO₂ 1.0); b) Baseline FiO₂ ≥ 0.5: one-step hyperoxic stimulus (FiO₂ 1.0) Exclusion Criteria: * Age \<18 years * Pregnancy * Extracorporeal membrane oxygenation (ECMO) * Continuous renal replacement therapy (CRRT) * Contraindications to hyperoxia, as judged by the treating physician * Severe hemodynamic instability requiring changes in vasopressor dose during the recording period * Inability to obtain a reliable transcranial Doppler signal through the temporal acoustic windows * Any clinical condition deemed by the treating physician to pose unacceptable risk during hyperoxic exposure
Where it's running
-
Erasme Hospital - ULB
Brussels, Belgium Recruiting
Study contacts
- Principal investigator: Fabio Silvio Taccone, MD, PhD — Hôpital Erasme - Université Libre de Bruxelles (ULB)
- Study coordinator: Michele Salvagno, MD
- Email: michele.salvagno@ulb.be
- Phone: +32471386614
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Permissive lung-protective ventilation in invasively ventilated adults
This study tests whether lowering the breathing rate during mechanical ventilation is better than standard lung-protective ventilation for adults in the ICU who need invasive ventilation.
-
Compare two ventilator modes in adults with cardiac ICU needs and invasive ventilation
This pilot tests whether volume-controlled versus pressure-controlled ventilation can be safely used in adults with heart disease and respiratory failure who need invasive ventilation.
-
Neuromuscular electrical stimulation for patients on invasive mechanical ventilation (MOVCARE)
We will test whether adding neuromuscular electrical stimulation to usual physical therapy helps adults on invasive mechanical ventilation regain leg muscle strength faster.
-
Monitoring diaphragm electrical activity and breathing effort during ventilator weaning
We will see if surface diaphragm EMG, esophageal pressure, and oxygen use measured during a spontaneous breathing trial can predict who will fail to wean from the ventilator in the ICU.
-
Combining chest X-rays and arterial blood gas results to predict ventilator need in critically ill adults
This project will test whether a computer model that uses chest X-rays and arterial blood gas results can predict which critically ill adults will need mechanical ventilation.
-
Comparing two ventilation modes for ICU patients
This study is trying to see which breathing support method, SIMV or MMV, works better for stable adult ICU patients by switching them between the two and monitoring their lung function.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.